Skip to content

To evaluate the efficacy of medicated enema therapy and external oleation therapy followed by oral medication in the management of hip joint pain.

An open label clinical trial to evaluate the efficacy of Basti along with Nitamba Basti followed by Kushmanda Ghrita in the management of Asthimajjagata Vata with special reference to Avascular Necrosis of Femoral Head - nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/07/070233
Enrollment
30
Registered
2024-07-09
Start date
Unknown
Completion date
Unknown
Last updated
2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M955- Acquired deformity of pelvis

Interventions

None listed

Sponsors

National Institute of Ayurveda
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patient having classical signs and symptoms of Asthimajaagata Vata. 2. Patient having signs and symptoms of avascular necrosis of femoral head 3. Patients fit for Basti therapy 4. Age- 18-60 years

Exclusion criteria

Exclusion criteria: 1. Patients unfit for Basti therapy 2. Patients known case of Sickle cell anaemia and thalassemia, uncontrolled Hypertension and any active and serious systemic diseases. 3. Pregnant& lactating women.

Design outcomes

Primary

MeasureTime frame
Changes in Harris Hip ScoreTimepoint: 61st day from baseline

Secondary

MeasureTime frame
Changes in sign and symptoms of Asthimajjagata Vata Changes in Range of Motion Changes in walking time Changes in quality of life Timepoint: 61st day from baseline

Countries

India

Contacts

Public ContactDr Gopesh Magal

national institute of ayurveda

gopesh.pk@nia.edu.in8619849011

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026